HST Global, Inc. income statement HSTC

Annual Quarterly

In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, HST Global, Inc. reported revenue of $0. It recorded a net loss of $13,792.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2024	Q3 FY2024 Sep 30, 2024	Q2 FY2024 Jun 30, 2024	Q1 FY2024 Mar 31, 2024	Q4 FY2023 Dec 31, 2023	Q3 FY2023 Sep 30, 2023	Q2 FY2023 Jun 30, 2023	Q1 FY2023 Mar 31, 2023	Q4 FY2022 Dec 31, 2022
Revenue	0	0	0	0	0	0	0	0	0
Selling, general and administrative	0 +90.4%	0 +206.8%	0 +453.7%	0 -66.7%	0 +19.3%	0 -4.8%	0 -34.0%	0 +10.1%	0 -0.2%
Operating income	-0 +29.9%	-0 +61.0%	-0 +49.8%	-0 +14.1%	-0 -2.6%	-0 +0.6%	-0 +4.5%	-0 -2.0%	-0 +0.0%
Interest expense	0 -32.2%	0 -71.2%	0 -93.6%	0 +23.0%	0 +26.9%	0 +29.8%	0 +32.4%	0 +37.5%	0 +39.9%
Other income (expense)	-0 +32.2%	-0 +71.2%	-0 +93.6%	-0 -23.0%	-0 -26.9%	-0 -29.8%	-0 -32.4%	-0 -37.5%	-0 -39.9%
Pretax income	—	-0 +61.4%	-0 +51.5%	-0 +13.0%	—	-0 -0.3%	-0 +3.4%	-0 -2.8%	—
Income tax	0	0	0	0	0	0	0	0	0
Net income	-0 +30.0%	-0 +61.4%	-0 +51.5%	-0 +13.0%	-0 -3.3%	-0 -0.3%	-0 +3.4%	-0 -2.8%	-0 -0.9%
Basic EPS	-0.00 +82.3%	0.00 +100.0%	0.00 +100.0%	-0.01	-0.01 -3.3%	-0.01 +0.0%	-0.01 +0.0%	—	-0.01
Weighted average shares, basic	21 +296.4%	41 +683.3%	32 +509.4%	5	5 +0.0%	5 +0.0%	5 +0.0%	—	5
Other measures
Interest coverage	-28.93x	-34.18x	-197.10x	-21.95x	-24.89x	-25.23x	-25.28x	-31.44x	-30.80x

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: HSTC (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Virginia Beach, VA
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 797564
Former names: NT HOLDING CORP. (until Mar 31, 2009); ABSS CORP (until Aug 12, 2004); UNICO INC (until May 22, 2002)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.